Laparoscopic Internal Gastric Banding, New Simple and Costless Weight Loss Procedure

Study the Effectiveness and Safety of Laparoscopic Internal Gastric Banding, New Simple and Costless Weight Loss Procedure, in Comparison to Laparoscopic Sleeve Gastrectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02878525

Acronym

LIGB

Enrollment

150

Registered

2016-08-25

Start date

2016-10-31

Completion date

2017-12-31

Last updated

2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

The purpose of this study is to study the effectiveness of laparoscopic internal gastric banding as a treatment for morbid obesity in comparison to laparoscopic sleeve gastrectomy

Detailed description

In this study 190 morbidly obese patients will be included and will randomly assign into 2 groups, group 1 will be operated by laparoscopic internal gastric banding and group 2 by laparoscopic sleeve gastrectomy, the patients will be followed up for 1 year to evaluate the effectiveness and drawbacks of laparoscopic internal gastric banding in comparison to laparoscopic sleeve gastrectomy, the investigators preparing to submit our study protocol to our institution ethical committee for approval to start the study

Interventions

PROCEDURELaparoscopic internal gastric banding

Laparoscopic internal gastric banding

PROCEDURElaparoscopic sleeve gastrectomy

laparoscopic sleeve gastrectomy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity * Approval to share in the study * Patients fit for laparoscopic surgery

Exclusion criteria

* Patient age less than 18 or more than 50 years old * Refusal to share in the study * Unfit for surgery * patients with gastroesophageal reflux disease clinically or by investigation

Design outcomes

Primary

Measure	Time frame	Description
safety of the technique	4 weeks	the incidence of introperative and early postoperative complications

Secondary

Measure	Time frame	Description
operative time	12 hours	the operative time from skin to skin
Hospital stay	30 days	Time of hospital stay
total cost	16 weeks	the total cost of the technique by US dollar and its early complications
Metabolic effect	6-12 months	Effect of the procedure on blood sugar, serum lipid and hypertension

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026